E70.1
Other hyperphenylalaninemias
Clinical Classification Guidelines
Medical Intelligence & Overview
E70.1 refers to a category of metabolic disorders known as other hyperphenylalaninemias. These conditions involve elevated levels of phenylalanine in the blood but differ from classic phenylketonuria (PKU). Hyperphenylalaninemias can vary in severity and impact, often requiring medical management to prevent complications. Understanding this condition is important for timely diagnosis and appropriate treatment to maintain health and prevent neurological issues.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting enzymes involved in phenylalanine metabolism Defects in enzymes other than phenylalanine hydroxylase, which is typically involved in classic PKU Underlying inherited metabolic disorders Secondary effects of other biochemical abnormalities
Key Symptoms: Mild to moderate intellectual disability if untreated Developmental delays Behavioral issues such as irritability or hyperactivity Skin conditions like eczema or dryness Possible neurological signs like seizures in severe cases Delayed speech and motor development
Diagnostic & Treatment
Diagnosis Path: Diagnosis of hyperphenylalaninemias involves blood tests that measure phenylalanine levels. Additional testing, such as enzyme activity assays and genetic testing, can identify specific enzyme deficiencies or mutations responsible for the condition. Newborn screening programs often detect elevated phenylalanine levels early, enabling prompt management. Imaging studies may be used to assess neurological impact if symptoms are present.
Treatment Protocols: Management of other hyperphenylalaninemias typically includes dietary interventions to restrict phenylalanine intake. In some cases, medications or enzyme substitution therapies may be recommended. Regular monitoring of blood phenylalanine levels is crucial to adjust diet and treatment plans. Early intervention, especially in infants diagnosed through screening, can significantly improve long-term outcomes. Supportive therapies such as speech, occupational, or behavioral therapy may be beneficial to address developmental challenges.
Clinical Advice & FAQs
Billing Guidance
Is E70.1 a billable ICD-10 code?
Yes, E70.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E70.1?
Clinical documentation must specify the nature of Other hyperphenylalaninemias and any associated comorbidities for accurate reporting.
Cite this Clinical Reference